Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

Stopped The futility analysis of study NCT00910091 in patients with endometrial cancer shows that the primary endpoint will not be reached.

Conditions

• Endometrial Cancer

Interventions

• DRUG: BN83495

Sponsor

Ipsen